A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers

Condition: HealthyInterventions: Drug: Olostar Tab.; Drug: Co-administration of Olmetec and CrestorSponsor: Daewoong Pharmaceutical Co. LTD.Enrolling by invitation - verified September 2015

http://clinicaltrials.gov/ct2/show/NCT02561884?lup_s=09%2F04%2F2015&lup_d=30

Source: ClinicalTrials.gov - September 24, 2015 Category: Research Source Type: clinical trials